PELICAN – Prematurity’s Effects on the Lungs In Children and Adults Network
- Dr Simpson Shannon (Telethon Kids Institute, Perth, Australia)
- Dr Jenny Hallberg (Karolinska Institutet, Stockholm, Sweden)
The PELICAN (Prematurity’s Effects on the Lungs in Children and Adults Network) clinical research collaboration was launched by the European Respiratory Society (ERS) in 2020. Although enhanced perinatal care has markedly improved survival outcomes for all preterm infants, there is clear evidence of poorer lung health outcomes in this population. PELICAN has the overarching objective to harmonise cross-sectional and longitudinal datasets globally, to describe the impact of preterm birth on lung health trajectories over its life course, and to determine which neonatal and lifetime exposures contribute to the progression of lung disease in this vulnerable population.
- To establish a preterm research network of clinicians and researchers for the improvement of long-term lung health research in the preterm population.
- To establish a global data repository of preterm cohorts for the prediction of life-long lung function trajectories and respiratory symptom profiles, and further evaluate the impact of regional clinical practice and treatments and exposures on lung health trajectories in this population.
- To establish standardised and well-defined outcome measures for describing prematurity effects on lung health and make recommendation for harmonising elements of cross-sectional and longitudinal studies.
- To promote education and patient/consumer engagement for the preterm community.
- To develop engagement with the existing ERS CRC Global Lung Function Initiative data repository.
The PELICAN Executive Scientific committee is composed of the CRC chairs, clinician researchers, experts in translational research, young investigators and patient representatives.
If you are interested in more information about PELICAN or would like to join the network, please contact firstname.lastname@example.org.